{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=89", "query": { "intervention": "Capsule 2", "page": 89 }, "page_size": 10 }, "pagination": { "page": 89, "page_size": 10, "total_count": 5061, "total_pages": 507, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=90&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=88&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-14T06:52:41.133Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01496365", "title": "Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "DS-5565 tablet", "type": "DRUG" }, { "name": "pregabalin capsule", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" }, { "name": "placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 452, "start_date": "2011-11-28", "completion_date": "2012-09-07", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 78, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01496365" }, { "nct_id": "NCT02786537", "title": "Study of Oral Treatments for Hepatitis C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Hepatitis C" ], "interventions": [ { "name": "SOF/LDV (sofosbuvir/ledipasvir)", "type": "DRUG" }, { "name": "PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only)", "type": "DRUG" }, { "name": "EBR/GZR (elbasvir/grazoprevir)", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1275, "start_date": "2016-06", "completion_date": "2020-09-02", "has_results": true, "last_update_posted_date": "2021-12-06", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 38, "location_summary": "Little Rock, Arkansas • Palo Alto, California • San Diego, California + 27 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02786537" }, { "nct_id": "NCT00893919", "title": "Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prophylaxis of Organ Rejection" ], "interventions": [ { "name": "mycophenolate mofetil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 37, "start_date": "2005-11", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893919" }, { "nct_id": "NCT02330419", "title": "Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Binge Drinking", "HIV" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Naltrexone", "type": "DRUG" }, { "name": "Medical Management (MM) counseling for alcohol use:", "type": "BEHAVIORAL" }, { "name": "Urinalysis for novel alcohol biochemical markers:", "type": "DIAGNOSTIC_TEST" }, { "name": "Behavioral survey measurements:", "type": "BEHAVIORAL" }, { "name": "Dried Blood Spot (DSB) Testing for Phosphatidylethanol", "type": "DIAGNOSTIC_TEST" }, { "name": "Ecological Momentary Assessment", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "18 Years to 70 Years · Male only" }, "enrollment_count": 120, "start_date": "2015-04", "completion_date": "2021-01", "has_results": true, "last_update_posted_date": "2025-04-20", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02330419" }, { "nct_id": "NCT05055128", "title": "A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Erosive Esophagitis" ], "interventions": [ { "name": "X842", "type": "DRUG" }, { "name": "X842 Dummy", "type": "DRUG" }, { "name": "Lansoprazole", "type": "DRUG" }, { "name": "Lansoprazole Dummy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cinclus Pharma Holding AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 248, "start_date": "2021-08-11", "completion_date": "2022-09-01", "has_results": true, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05055128" }, { "nct_id": "NCT03523728", "title": "A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Polycystic Kidney, Autosomal Dominant" ], "interventions": [ { "name": "Venglustat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 478, "start_date": "2018-10-04", "completion_date": "2021-08-03", "has_results": true, "last_update_posted_date": "2023-02-03", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03523728" }, { "nct_id": "NCT06418607", "title": "A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Venglustat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 65, "start_date": "2020-06-23", "completion_date": "2020-07-13", "has_results": false, "last_update_posted_date": "2024-05-17", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 2, "location_summary": "Miami, Florida • Saint Paul, Minnesota", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06418607" }, { "nct_id": "NCT01336634", "title": "Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "Dabrafenib", "type": "DRUG" }, { "name": "Trametinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 177, "start_date": "2011-08-05", "completion_date": "2021-01-07", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 15, "location_summary": "Los Angeles, California • Orange, California • Aurora, Colorado + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01336634" }, { "nct_id": "NCT05375539", "title": "AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "AGN-Cogni.Q", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 12, "start_date": "2023-05-02", "completion_date": "2025-02-15", "has_results": true, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05375539" }, { "nct_id": "NCT01259492", "title": "Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Attention Deficit/Hyperactivity Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Ritalin LA 20 mg", "type": "DRUG" }, { "name": "Ritalin LA 30 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 725, "start_date": "2010-11", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-10-07", "last_synced_at": "2026-11-14T06:52:41.133Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Beverly Hills, California • Spring Valley, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01259492" } ] }